BioSenic S.A. (0R55.L)

EUR 0.01

(-14.29%)

Total Liabilities Summary of BioSenic S.A.

BioSenic S.A.'s latest annual total liabilities in 2023 was 32.26 Million EUR , up 23.15% from previous year.
BioSenic S.A.'s latest quarterly total liabilities in 2024 Q2 was 29.8 Million EUR , down 0.0% from previous quarter.
BioSenic S.A. reported annual total liabilities of 26.2 Million EUR in 2022, down -1.27% from previous year.
BioSenic S.A. reported annual total liabilities of 26.53 Million EUR in 2021, up 23.37% from previous year.
BioSenic S.A. reported quarterly total liabilities of 29.8 Million EUR for 2024 Q1, down -7.64% from previous quarter.
BioSenic S.A. reported quarterly total liabilities of 32.26 Million EUR for 2023 Q3, up 15.56% from previous quarter.

Annual Total Liabilities Chart of BioSenic S.A. (2023 - 2011)

Historical Annual Total Liabilities of BioSenic S.A. (2023 - 2011)

Year	Total Liabilities	Total Liabilities Growth
2023	32.26 Million EUR	23.15%
2022	26.2 Million EUR	-1.27%
2021	26.53 Million EUR	23.37%
2020	21.51 Million EUR	5.73%
2019	20.34 Million EUR	-4.31%
2018	21.26 Million EUR	-6.7%
2017	22.79 Million EUR	-2.25%
2016	23.31 Million EUR	4.85%
2015	22.23 Million EUR	-33.99%
2014	33.68 Million EUR	164.25%
2013	12.74 Million EUR	8.22%
2012	11.78 Million EUR	4.79%
2011	11.24 Million EUR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	29.8 Million EUR	0.0%
2024 Q1	29.8 Million EUR	-7.64%
2023 Q3	32.26 Million EUR	15.56%
2023 Q4	32.26 Million EUR	0.0%
2023 Q1	27.92 Million EUR	6.56%
2023 Q2	27.92 Million EUR	0.0%
2023 FY	32.26 Million EUR	23.15%
2022 Q3	26.2 Million EUR	20.72%
2022 FY	26.2 Million EUR	-1.27%
2022 Q4	26.2 Million EUR	0.0%
2022 Q2	21.7 Million EUR	0.0%
2021 Q2	17.17 Million EUR	0.0%
2021 Q4	26.53 Million EUR	0.0%
2021 FY	26.53 Million EUR	23.37%
2020 Q2	27.22 Million EUR	0.0%
2020 FY	21.51 Million EUR	5.73%
2020 Q4	21.51 Million EUR	0.0%
2019 FY	20.34 Million EUR	-4.31%
2019 Q2	21.98 Million EUR	0.0%
2019 Q4	20.34 Million EUR	0.0%
2018 FY	21.26 Million EUR	-6.7%
2018 Q4	21.26 Million EUR	0.0%
2018 Q2	20.41 Million EUR	0.0%
2017 FY	22.79 Million EUR	-2.25%
2017 Q4	22.79 Million EUR	0.0%
2017 Q2	20.94 Million EUR	0.0%
2016 Q4	23.31 Million EUR	0.0%
2016 Q2	20.96 Million EUR	0.0%
2016 FY	23.31 Million EUR	4.85%
2015 Q2	16.41 Million EUR	0.0%
2015 FY	22.23 Million EUR	-33.99%
2015 Q4	22.23 Million EUR	0.0%
2014 FY	33.68 Million EUR	164.25%
2014 Q4	33.68 Million EUR	127.91%
2014 Q3	14.78 Million EUR	0.0%
2013 Q4	12.74 Million EUR	0.0%
2013 FY	12.74 Million EUR	8.22%
2012 FY	11.78 Million EUR	4.79%
2011 FY	11.24 Million EUR	0.0%

Peer Total Liabilities Comparison of BioSenic S.A.

Name	Total Liabilities	Total Liabilities Difference
Boiron SA	198.7 Million EUR	83.763%
Laboratorios Farmaceuticos Rovi, S.A.	256.39 Million EUR	87.416%
Vetoquinol SA	165.12 Million EUR	80.461%
Valneva SE	341.14 Million EUR	90.542%
AB Science S.A.	46.5 Million EUR	30.627%
Nanobiotix S.A.	95.74 Million EUR	66.3%
PHAXIAM Therapeutics S.A.	25.69 Million EUR	-25.565%
Vivoryon Therapeutics N.V.	4.54 Million EUR	-609.567%
ABIVAX Société Anonyme	131.05 Million EUR	75.381%
Formycon AG	387.61 Million EUR	91.676%